Columbia University Skin Disease Resource-Based Center (epiCURE)
哥伦比亚大学皮肤病资源中心 (epiCURE)
基本信息
- 批准号:9765045
- 负责人:
- 金额:$ 77.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAdoptedAlgorithmsAreaAwarenessBasic ScienceBiologyBiomedical ResearchChargeClinicClinicalClinical ResearchClinical effectivenessCollaborationsCommunitiesCore FacilityCountryCutaneousDermatologyDevelopmentDiseaseDisease modelElementsEnvironmentFeasibility StudiesFosteringFutureGoalsImmunityInstitute of Medicine (U.S.)InstitutionInternationalInvestigationMissionNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNerveNew YorkPathologicPatientsPhasePilot ProjectsPre-Clinical ModelQuality of lifeResearchResearch PersonnelResearch Project GrantsResearch TrainingResourcesScientistServicesSkinStem cellsStrategic PlanningStructureTraining and EducationTranslatingTranslational ResearchUniversitiesbasecellular imagingcommunity based participatory researchdesignfundamental researchimprovedinnovationmetropolitanmultidisciplinarypre-clinicalpre-clinical researchprecision medicinepreclinical efficacyprogramspublic health relevanceresponseskin disordersoundsuccesstranslational medicine
项目摘要
DESCRIPTION (provided by applicant): This application proposes the creation of a Skin Disease Resource-Based Core center at Columbia University (epiCURE). The epiCURE is designed to address critical roadblocks on the Continuum of Translational research as defined by the Institute of Medicine. The continuum defines three critical translational phases in biomedical research: basic science into pre-clinical efficacy into clinical effectiveness. The Cores of the epiCURE center have been strategically configured to address these critical phases in skin disease research, and provide a unique set of services and resources to facilitate advancement of the Research Community along the translational continuum pipeline that is driven by a Precision Medicine-based algorithm and is responsive to the NIAMS mission. The epiCURE Center, and the Institutional Commitment that accompanies it, can accomplish this goal by providing a uniquely effective service-based vehicle for investigator interactions that further education, training and research in cutaneous biology and skin disease. The configuration of the epiCURE represents a natural, logical progression built on the previous successes of our existing SDRC over the past 18 years, in bridging basic discoveries and translational research, and catalyzing their entry into the clinic. We have given very careful consideration to selecting the service and resource components of the epiCURE so that they bolster the existing research excellence at Columbia University and the broader Research Community, which is comprised of 37 investigators at Columbia University as well as 37 investigators at other 18 institutions in the New York metropolitan area and across the country. In addition to an Administrative Core and innovative Enrichment Program, the epiCURE is structured around three Service Cores that span a continuum of basic, pre-clinical and translational research: 1) Skin Stem Cell Imaging and Manipulation (SCIM); 2) Skin Immunity, Integrity and Disease Models (SIND); and 3) Translational and Precision Medicine Resources (TRAP). The overall goal of the epiCURE center is to break down barriers to translational research, and accelerate the progress of investigation in skin disease research to rapidly advance from basepairs to bedside.
描述(由应用程序提供):本申请提出了哥伦比亚大学(Epicure)的基于皮肤疾病的核心中心的创建。该Epicure旨在解决医学研究所所定义的转化研究连续体的关键障碍。连续体定义了生物医学研究中的三个关键翻译阶段:基础科学对临床有效性的临床前有效性。 Epicure Center的核心已在战略上配置为解决皮肤病研究中的这些关键阶段,并提供了一套独特的服务和资源,以促进研究社区沿翻译连续管道的发展,这是由基于精确医学的算法驱动的,并且对NIAMS的响应迅速。 Epicure Center以及涉及它的机构承诺,可以通过为研究人员的相互作用提供基于服务的独特的工具来实现这一目标,以进一步教育,培训和研究皮肤生物学和皮肤病。 Epicure的配置代表了过去18年中现有SDRC的先前成功建立的自然,逻辑上的进展,这是在弥合基本发现和翻译研究的过程中,并促进了他们进入诊所的进入。我们已经非常仔细地考虑了Epicure的服务和资源组成部分。因此,他们加强了哥伦比亚大学和更广泛的研究社区的现有研究卓越,由哥伦比亚大学的37名调查员以及纽约大都会地区和全国其他18个机构的37个调查员组成。除了行政核心和创新的富集计划外,该Epicure还围绕三个服务核心构建,这些服务核心跨越了基本的,临床前和翻译的研究:1)皮肤干细胞成像和操纵(SCIM); 2)皮肤免疫,完整性和疾病模型(SIND); 3)翻译和精密医学资源(陷阱)。 Epicure Center的总体目标是打破翻译研究的障碍,并加速皮肤病研究的研究进展,从而迅速从底层底部发展到床边。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID RINSEY BICKERS其他文献
DAVID RINSEY BICKERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID RINSEY BICKERS', 18)}}的其他基金
Tumor Immune Profiling to Optimize Clinical Trial Readiness in Basal Cell Nevus Syndrome
肿瘤免疫分析可优化基底细胞痣综合征的临床试验准备
- 批准号:
10046642 - 财政年份:2020
- 资助金额:
$ 77.12万 - 项目类别:
Molecular Mechanisms Underlying the Prevention of BCC Resistance
预防 BCC 耐药性的分子机制
- 批准号:
10552026 - 财政年份:2020
- 资助金额:
$ 77.12万 - 项目类别:
Molecular Mechanisms Underlying the Prevention of BCC Resistance
预防 BCC 耐药性的分子机制
- 批准号:
10330598 - 财政年份:2020
- 资助金额:
$ 77.12万 - 项目类别:
Molecular Mechanisms Underlying the Prevention of BCC Resistance
预防 BCC 耐药性的分子机制
- 批准号:
9974157 - 财政年份:2020
- 资助金额:
$ 77.12万 - 项目类别:
Tumor Immune Profiling to Optimize Clinical Trial Readiness in Basal Cell Nevus Syndrome
肿瘤免疫分析可优化基底细胞痣综合征的临床试验准备
- 批准号:
10221074 - 财政年份:2020
- 资助金额:
$ 77.12万 - 项目类别:
Columbia University Skin Disease Resource-Based Center (epiCURE)
哥伦比亚大学皮肤病资源中心 (epiCURE)
- 批准号:
9087989 - 财政年份:2016
- 资助金额:
$ 77.12万 - 项目类别:
Non-melanoma skin cancer: A model for impact of aging on an environmental disease
非黑色素瘤皮肤癌:衰老对环境疾病影响的模型
- 批准号:
9204120 - 财政年份:2016
- 资助金额:
$ 77.12万 - 项目类别:
Mechanism-based abrogation of BCC pathogenesis
基于机制的 BCC 发病机制的消除
- 批准号:
8460080 - 财政年份:2012
- 资助金额:
$ 77.12万 - 项目类别:
Mechanism-based abrogation of BCC pathogenesis
基于机制的 BCC 发病机制的消除
- 批准号:
8610310 - 财政年份:2012
- 资助金额:
$ 77.12万 - 项目类别:
Mechanism-based abrogation of BCC pathogenesis
基于机制的 BCC 发病机制的消除
- 批准号:
8296459 - 财政年份:2012
- 资助金额:
$ 77.12万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 77.12万 - 项目类别:
AnVIL Clinical Environment for Innovation and Translation (ACE-IT)
AnVIL 创新与转化临床环境 (ACE-IT)
- 批准号:
10747551 - 财政年份:2023
- 资助金额:
$ 77.12万 - 项目类别:
Use of electronic health records in underserved communities in Florida
在佛罗里达州服务欠缺的社区使用电子健康记录
- 批准号:
10580502 - 财政年份:2023
- 资助金额:
$ 77.12万 - 项目类别: